Mahaney Paige
SEC insider (Form 3/4/5 filer). CIK 0002040313. Chief Scientific Officer at C4 Therapeutics, Inc. (CCCC). 7 reported Form 4/5 transactions since Sep 2024; latest on Feb 14, 2026. Located in WATERTOWN, MA.
Companies Mahaney Paige has filed insider reports for
- C4 Therapeutics, Inc. (CCCC): Officer, Chief Scientific Officer
Mahaney Paige
CIK: 0002040313
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (28.6%)
Derivative conversions
Awards (A)3 (42.9%)
Compensation grants
Other (G, F, J, C, D, …)2 (28.6%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CCCC
C4 Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Feb 14, 2026CCCC
C4 Therapeutics, Inc.
ExerciseDirect7.1K shares- - Feb 14, 2026CCCC
C4 Therapeutics, Inc.
Tax PaymentDirect2.4K shares at avg. $1.89$5K - Feb 13, 2026CCCC
C4 Therapeutics, Inc.
AwardDirect240K shares- - Oct 28, 2025CCCC
C4 Therapeutics, Inc.
ExerciseDirect19.2K shares- - Oct 28, 2025CCCC
C4 Therapeutics, Inc.
Tax PaymentDirect5.6K shares at avg. $2.58$15K - Feb 14, 2025CCCC
C4 Therapeutics, Inc.
AwardDirect28.2K shares- - Oct 28, 2024CCCC
C4 Therapeutics, Inc.
AwardDirect76.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc. | Exercise | 7,050 | - | $0 | Direct |
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc. | Tax Payment | 2,446 | $1.89 | $4,623 | Direct |
| Feb 13, 2026 | CCCC C4 Therapeutics, Inc. | Award | 240,000 | - | $0 | Direct |
| Oct 28, 2025 | CCCC C4 Therapeutics, Inc. | Exercise | 19,200 | - | - | Direct |
| Oct 28, 2025 | CCCC C4 Therapeutics, Inc. | Tax Payment | 5,644 | $2.58 | $14,562 | Direct |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | Award | 28,200 | - | - | Direct |
| Oct 28, 2024 | CCCC C4 Therapeutics, Inc. | Award | 76,800 | - | $0 | Direct |
1-7 of 7 transactions